根治性切除ⅢA期-N2非小细胞肺癌的术后放疗-王绿化-2009CSCO年会PPT.ppt

Overall Survival P=0.007 In Press: B. Zou Int. J. Radiation Oncology Biol. Phys., Vol. -, No. -, pp. 1–8, 2009 Disease Free Survival P=0.003 In Press: B. Zou Int. J. Radiation Oncology Biol. Phys., Vol. -, No. -, pp. 1–8, 2009 Local Recurrence Free Survival P=0.027 In Press: B. Zou Int. J. Radiation Oncology Biol. Phys., Vol. -, No. -, pp. 1–8, 2009 Prognostic Factors 3 Cycles of chemotherapy P=0.035 CONCLUSION As compared with POCT alone, POCRT improves survival in patients with completely resected Stage III–N2 nodal disease in NSCLC. In Press: B. Zou Int. J. Radiation Oncology Biol. P